Oberweis Asset Management’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-52,250
Closed -$4.02M 179
2017
Q2
$4.02M Buy
52,250
+400
+0.8% +$29.9K 1.1% 31
2017
Q1
$3.87M Sell
51,850
-170
-0.3% -$12.3K 1.14% 30
2016
Q4
$3.5M Buy
52,020
+250
+0.5% +$16.1K 1.05% 31
2016
Q3
$3.45M Sell
51,770
-4,810
-9% -$306K 0.99% 31
2016
Q2
$3.38M Sell
56,580
-8,430
-13% -$456K 1% 32
2016
Q1
$3.16M Buy
65,010
+53,510
+465% +$2.43M 0.91% 37
2015
Q4
$622K Buy
11,500
+4,900
+74% +$250K 0.17% 98
2015
Q3
$318K Sell
6,600
-100
-1% -$5.17K 0.09% 132
2015
Q2
$317K Sell
6,700
-2,000
-23% -$93.5K 0.08% 140
2015
Q1
$400K Buy
+8,700
New +$404K 0.11% 116

Other funds holding NUVA

Oberweis Asset Management's NUVA Position: Q3 2017 in Review

Oberweis Asset Management sold out of NuVasive, Inc. (NUVA) in Q3 2017, closing a stake of 52,250 shares — an estimated $4.02M sold.

Oberweis Asset Management first reported a position in NUVA in Q1 2015 and held it in 10 quarters. The position peaked at $4.02M in Q2 2017. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2017.

  • Oberweis Asset Management reported no remaining NuVasive, Inc. position as of Q3 2017 after selling out during the quarter.
  • Oberweis Asset Management sold 52,250 NuVasive, Inc. shares in Q3 2017, an estimated $4.02M.
  • Oberweis Asset Management first reported a position in NuVasive, Inc. in Q1 2015 and held it in 10 quarters.
  • Oberweis Asset Management's NuVasive, Inc. position peaked at $4.02M in Q2 2017.
  • 263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2017.

Based on Oberweis Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.